Medication info
Exdipin Tablet 5/160 mg

Exdipin Tablet 5/160 mg

Prescription medicationTabletOral
Ingredient · strength
Valsartan›160mg / 1 tabletAmlodipine Besylate›6.94mg / 1 tablet
Manufacturer / importer
Korea Prime Pharmaceutical Co., Ltd.
Appearance
Dark yellow oval film-coated tablet
Packaging
28 tablets (14 tablets/Alu-AluX2)
Approval status
Active

MFDS item code 201506857 · Approved 2015.09.30 · Insurance code 663606360

Summary

Main use
Treatment of essential hypertension not controlled with monotherapy
Who takes it
Adults · Children
Adult dose
The recommended dose of this medicine is 1 tablet once daily, taken with water, with or without food. It is recommended that it be taken at the same time each day, if possible (e.g., in the morning). Before administering this medicine, it is recommended that the dose be adjusted using the individual components (amlodipine or valsartan); however, a direct switch to this medicine may be considered if blood pressure is not adequately controlled with monotherapy with the individual components, as follows. ㆍ5/80 mg: Administer to patients whose blood pressure is not adequately controlled with amlodipine 5 mg or valsartan 80 mg monotherapy. ㆍ5/160 mg: Administer to patients whose blood pressure is not adequately controlled with amlodipine 5 mg or valsartan 160 mg monotherapy. ㆍ10/160 mg: Administer to patients whose blood pressure is not adequately controlled with amlodipine 10 mg or valsartan 160 mg monotherapy, or with 5/160 mg. Patients taking valsartan and amlodipine concomitantly may switch to this medicine (a combination product containing the same amount of each active ingredient) for convenience. Patients with renal impairment: No dosage adjustment is necessary in patients with mild or moderate renal impairment (creatinine clearance 10mL/min or more), but this medicine should not be administered to patients with severe renal impairment (creatinine clearance below 10mL/min) or patients on dialysis. Monitoring of potassium levels and creatinine is recommended in patients with moderate renal impairment. Patients with hepatic impairment: In patients with mild or moderate hepatic impairment, the daily dose of valsartan should not exceed 80 mg. Do not administer this medicine to patients with severe hepatic impairment, biliary cirrhosis, or biliary obstruction or cholestasis. Older adults aged 65 years and over: Exercise caution when increasing the dose.
Child dose
Pediatric patients under 18 years of age: Use of this medicine is not recommended.

Ingredients

Manufacturer
Korea Prime Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of essential hypertension not controlled with monotherapy

  • Essential hypertension
View approved original text

This medication can be used to more effectively manage essential hypertension when blood pressure is not sufficiently controlled by monotherapy with either amlodipine or valsartan.

How to take

Adult dose

The recommended dose of this medicine is 1 tablet once daily, taken with water, with or without food. It is recommended that it be taken at the same time each day, if possible (e.g., in the morning). Before administering this medicine, it is recommended that the dose be adjusted using the individual components (amlodipine or valsartan); however, a direct switch to this medicine may be considered if blood pressure is not adequately controlled with monotherapy with the individual components, as follows. ㆍ5/80 mg: Administer to patients whose blood pressure is not adequately controlled with amlodipine 5 mg or valsartan 80 mg monotherapy. ㆍ5/160 mg: Administer to patients whose blood pressure is not adequately controlled with amlodipine 5 mg or valsartan 160 mg monotherapy. ㆍ10/160 mg: Administer to patients whose blood pressure is not adequately controlled with amlodipine 10 mg or valsartan 160 mg monotherapy, or with 5/160 mg. Patients taking valsartan and amlodipine concomitantly may switch to this medicine (a combination product containing the same amount of each active ingredient) for convenience. Patients with renal impairment: No dosage adjustment is necessary in patients with mild or moderate renal impairment (creatinine clearance 10mL/min or more), but this medicine should not be administered to patients with severe renal impairment (creatinine clearance below 10mL/min) or patients on dialysis. Monitoring of potassium levels and creatinine is recommended in patients with moderate renal impairment. Patients with hepatic impairment: In patients with mild or moderate hepatic impairment, the daily dose of valsartan should not exceed 80 mg. Do not administer this medicine to patients with severe hepatic impairment, biliary cirrhosis, or biliary obstruction or cholestasis. Older adults aged 65 years and over: Exercise caution when increasing the dose.

Child dose

Pediatric patients under 18 years of age: Use of this medicine is not recommended.

Precautions

This medication can cause serious harm to the fetus and newborn when taken during the second and third trimesters of pregnancy; therefore, it should be discontinued immediately upon confirmation of pregnancy. Patients with allergies to this drug's active ingredients or similar medications, pregnant or breastfeeding women, patients with severe kidney or liver dysfunction, and those with a history of angioedema should not take this medication. Patients with low sodium or fluid levels in the body may experience hypotension, so it is important to check their condition before taking the medication and to carefully monitor blood pressure and symptoms during use. Patients with high potassium levels may experience increased potassium concentration when taking this medication along with potassium-containing drugs or supplements, necessitating periodic blood tests. Patients with vascular issues in the kidneys or those who have received kidney transplants should use this medication with caution due to the risk of worsening kidney function. If symptoms of angioedema, such as swelling of the face, lips, or tongue, or difficulty breathing occur during treatment, the medication should be stopped immediately and medical advice sought. Patients with heart failure or post-myocardial infarction should closely monitor kidney function and blood pressure while taking this medication, and patients with acute myocardial infarction may experience worsening angina symptoms while on this drug, so caution is advised. Dosing for patients with liver dysfunction should be limited, and any signs of liver dysfunction should be reported to a healthcare professional. Care should be taken when driving or operating machinery, as dizziness or fatigue may occur. Taking this medication in combination with other antihypertensives, potassium supplements, and NSAIDs can increase the risk of side effects due to interactions, so patients should consult with their doctor or pharmacist. Women who are pregnant or planning to become pregnant should not take this medication, and breastfeeding women are also advised to avoid it. The safety and efficacy for pediatric patients under 18 years old have not been established, and its use is therefore not recommended. In case of overdose, hypotension and heart-related problems may occur; thus, it is essential to adhere to the prescribed dosage and contact health professionals immediately if symptoms arise.

Side effects

Nasopharyngitis, Influenza, Hypersensitivity, Visual impairment, Anxiety, Headache, Dizziness, Drowsiness, Orthostatic dizziness, Paresthesia, Vertigo, Tinnitus, Tachycardia, Palpitations, Syncope, Orthostatic hypotension, Hypotension, Cough, Pain in the throat and larynx, Diarrhea, Nausea, Abdominal pain, Constipation, Thirst, Rash, Erythema, Hyperhidrosis, Itching, Joint swelling, Low back pain, Arthritis, Muscle spasms, Lethargy, Pollakiuria, Polyuria, Erectile dysfunction, Edema, Peripheral edema, Facial edema, Generalized edema, Fatigue, Flushing, Myasthenia, Facial flushing, Decreased hemoglobin, Decreased hematocrit, Neutropenia, Thrombocytopenia, Including hypersensitivity to serum sickness, Increased serum potassium, Vasculitis, Elevated liver function tests, Angioedema, Myalgia, Renal failure, Kidney injury, Increased serum creatinine, Insomnia, Decreased libido, Pharyngitis, Rhinitis, Sinusitis, Upper respiratory infection, Viral infection, Diplopia, Thrombocytopenia, Leukopenia, Allergic reaction, Hyperglycemia, Insomnia, Mood changes, Tremors, Sensory impairment, Dysgeusia, Peripheral neuropathy, Hypertonicity, Arrhythmia, Bradycardia, Atrial fibrillation, Ventricular tachycardia, Myocardial infarction, Vasculitis, Dyspnea, Rhinitis, Vomiting, Dyspepsia, Pancreatitis, Gastritis, Gingival hyperplasia, Hepatitis, Jaundice, Alopexia, Purpura, Skin depigmentation, Photosensitivity reaction, Angioedema, Urticaria, Erythema multiforme, Stevens-Johnson syndrome, Myalgia, Urinary disturbances, Nocturia, Gynecomastia, Pain, Apathy, Chest pain, Weight loss, Weight gain, Elevated liver enzymes, Chest discomfort, Abdominal discomfort, Gastroesophageal reflux, Neck pain, Hypercholesterolemia, Hypoglycemia, Neuroagitation, Stevens-Johnson syndrome, Chest pain, Weight gain, Arthralgia, Skeletal pain, Rhabdomyolysis, Gingival hyperplasia, Gastritis, Sensory impairment

Not everyone experiences these, and they can vary from person to person.

Storage

This medication may be sensitive to air or moisture; therefore, it should be stored in a tightly sealed container. Additionally, it should be kept in a cool room temperature between 1 and 30 degrees Celsius. This helps to maintain the medication's effectiveness over time.

Appearance and packaging

Appearance

Dark yellow oval film-coated tablet

Package unit

28 tablets (14 tablets/Alu-AluX2)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.